advanced search

Welcome: Guest

log in

Covidien Ltd.Tyco Healthcare Product Pipeline Analysis

Publication Date May 2008
Publisher Global Markets Direct
Product Type Report
Pages 52
ISBN Number not applicable
Product Code GMD04862
Buy this product or for assistance call +44 20 7060 7474

Summary

This report is an insightful source for data, analysis and strategic insights into a Covidien Ltd.Tyco Healthcare's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reason to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook - Cardiovascular Devices
    • 2.5 Industry Outlook - Anesthesia and Respiratory Devices
    • 2.6 Industry Outlook - Hospital Supplies
    • 2.7 Industry Outlook - In Vitro Diagnostics
    • 2.8 SWOT Snapshot
  • 3 Covidien Ltd./Tyco Healthcare Pipeline Products
    • 3.1 Covidien Ltd./Tyco Healthcare Product Pipeline Analysis
      • 3.1.1 Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
      • 3.1.2 Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage
      • 3.1.3 Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area
      • 3.1.4 Covidien Ltd./Tyco Healthcare Pipeline Products By News Summary
    • 3.2 PleuraSeal Lung Sealant System
      • 3.2.1 Product Description
      • 3.2.2 Product Status
      • 3.2.3 Product Milestone
    • 3.3 Sandman Intro CPAP Device
      • 3.3.1 Product Description
      • 3.3.2 Product Status
      • 3.3.3 Product Milestone
    • 3.4 Contrast Delivery System
      • 3.4.1 Product Description
      • 3.4.2 Product Status
      • 3.4.3 Product Milestone
  • 4 Business Description
    • 4.1 Business Overview
    • 4.2 Imaging Solutions
      • 4.2.1 Overview
      • 4.2.2 Financials
      • 4.2.3 Capital Expenditure
      • 4.2.4 Market View
      • 4.2.5 Key Strategies
    • 4.3 Medical Devices
      • 4.3.1 Overview
      • 4.3.2 Financials
      • 4.3.3 Capital Expenditure
      • 4.3.4 Market View
      • 4.3.5 Key Strategies
    • 4.4 Medical Supplies
      • 4.4.1 Overview
      • 4.4.2 Financials
      • 4.4.3 Capital Expenditure
      • 4.4.4 Market View
      • 4.4.5 Key Strategies
    • 4.5 Pharmaceutical Products
      • 4.5.1 Overview
      • 4.5.2 Financials
      • 4.5.3 Capital Expenditure
      • 4.5.4 Market View
      • 4.5.5 Key Strategies
    • 4.6 Retail Products
      • 4.6.1 Overview
      • 4.6.2 Financials
      • 4.6.3 Capital Expenditure
      • 4.6.4 Market View
      • 4.6.5 Key Strategies
    • 4.7 Major Products and Services
      • 4.7.1 Overview
  • 5 History
  • 6 Competitors
  • 7 Key Employees
  • 8 Key Employee Biographies
  • 9 Company Statement
  • 10 Locations And Subsidiaries
    • 10.1 Head Office
    • 10.2 Other Locations & Subsidiaries
  • 11 Financial Deals Landscape
    • 11.1 Acquisition
      • 11.1.1 Covidien Acquires Tissue Science Laboratories
      • 11.1.2 Covidien Acquires Scandius Biomedical
    • 11.2 Debt Offerings
      • 11.2.1 Covidien International Finance Completes Private Placement Of $2,750 Million
    • 11.3 Partnership
      • 11.3.1 Covidien Signs An Agreement With Allergan
      • 11.3.2 Covidien And BioSynthema Enter Into Licensing Agreement
  • 12 Recent Developments
    • 12.1 Strategy and Business Planning
      • 12.1.1 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
    • 12.2 Financial Announcements
      • 12.2.1 May 06, 2008: Covidien Declares Q2 Fiscal 2008 Results
      • 12.2.2 Apr 09, 2008: Covidien To Declare Q2 2008 Results
      • 12.2.3 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
      • 12.2.4 Mar 18, 2008: Covidien Declares Quarterly Dividend
      • 12.2.5 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
      • 12.2.6 Jan 15, 2008: Covidien Declares Quarterly Dividend
      • 12.2.7 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
      • 12.2.8 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
      • 12.2.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
      • 12.2.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
    • 12.3 Other Significant Developments
      • 12.3.1 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
  • 13 Appendix
    • 13.1 Methodology
      • 13.1.1 Coverage
      • 13.1.2 Secondary Research
      • 13.1.3 Primary Research
      • 13.1.4 Expert Panel Validation
    • 13.2 Contact Us
    • 13.3 About Global Markets Direct
    • 13.4 Disclaimer
  • List of Tables
    • Table 1: Covidien Ltd./Tyco Healthcare,Key Facts, 2007
    • Table 2: Covidien Ltd./Tyco Healthcare Pipeline Products by Equipment Type
    • Table 3: Covidien Ltd./Tyco Healthcare Pipeline Products By Development Stage
    • Table 4: Covidien Ltd./Tyco Healthcare Pipeline Products By Therapy Area
    • Table 5: Covidien Ltd./Tyco Healthcare Pipeline Products By News Summaries
    • Table 6: Covidien Ltd./Tyco Healthcare, Key Employees, 2007
    • Table 7: Covidien Ltd./Tyco Healthcare, Other Locations
    • Table 8: Covidien Ltd./Tyco Healthcare, Subsidiaries
  • List of Figures
    • Figure 1: Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
    • Figure 2: Covidien Ltd./Tyco Healthcare Pipeline Products By Equipment Type
    • Figure 3: Global Markets Direct Methodology
Delivery Details

PDF:Delivered by email usually within 12 to 24 UK business hours.

Product features / use
Scope Expert Insight/Opinion yes
Features Primary Research Data yes

Industry Events